WASHINGTON (AP) -- FDA health panel endorses Merck COVID-19 pill, paving way for U.S. authorization of the first at-home drug for virus. huarihuang 发表于 2021-11-30 17:23
merck好像目前只投票通过了高危人群 https://www.cnbc.com/2021/11/30/fda-advisory-panel-narrowly-endorses-mercks-oral-covid-treatment-pill-despite-reduced-efficacy.html The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir. Molnupiravir is an oral antiviral drug designed to treat adults with mild to moderate symptoms of Covid-19 who are at high risk of severe disease. Most committee members agreed it was a difficult vote, with unanswered questions about the drug’s safety and potential impact, however unlikely, on driving virus evolution. The drug needs final authorization from the FDA and Centers for Disease Control and Prevention before it’s available to the public on an emergency basis.
merck好像目前只投票通过了高危人群 https://www.cnbc.com/2021/11/30/fda-advisory-panel-narrowly-endorses-mercks-oral-covid-treatment-pill-despite-reduced-efficacy.html The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir. Molnupiravir is an oral antiviral drug designed to treat adults with mild to moderate symptoms of Covid-19 who are at high risk of severe disease. Most committee members agreed it was a difficult vote, with unanswered questions about the drug’s safety and potential impact, however unlikely, on driving virus evolution. The drug needs final authorization from the FDA and Centers for Disease Control and Prevention before it’s available to the public on an emergency basis. vitd120 发表于 2021-11-30 17:52
merck好像目前只投票通过了高危人群 https://www.cnbc.com/2021/11/30/fda-advisory-panel-narrowly-endorses-mercks-oral-covid-treatment-pill-despite-reduced-efficacy.html The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir. Molnupiravir is an oral antiviral drug designed to treat adults with mild to moderate symptoms of Covid-19 who are at high risk of severe disease. Most committee members agreed it was a difficult vote, with unanswered questions about the drug’s safety and potential impact, however unlikely, on driving virus evolution. The drug needs final authorization from the FDA and Centers for Disease Control and Prevention before it’s available to the public on an emergency basis. vitd120 发表于 2021-11-30 17:52
WASHINGTON (AP) -- FDA health panel endorses Merck COVID-19 pill, paving way for U.S. authorization of the first at-home drug for virus. huarihuang 发表于 2021-11-30 17:23
Jerusalem Post没有确认这个消息。它只是说Channel 12 (应该是当地某电视台）报道了这个消息，但在文中同时也说：以色列卫生部还没有收到类似数据。楼主不贴以色列卫生部的段落会引起误解。 Later in the evening, a report by Channel 12 said the Pfizer vaccine is just slightly less effective in preventing infection with Omicron than with Delta – 90% as opposed to 95% – while it is as effective – around 93% – in preventing serious symptoms at least for those vaccinated with a booster. A spokesperson for the Health Ministry said the ministry was not yet in possession of the data published by Channel 12.
吹吧，现在说什么都太早
A spokesperson for the Health Ministry said the ministry was not yet in possession of the data published by Channel 12.
merck好像目前只投票通过了高危人群
https://www.cnbc.com/2021/11/30/fda-advisory-panel-narrowly-endorses-mercks-oral-covid-treatment-pill-despite-reduced-efficacy.html
The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir.
Molnupiravir is an oral antiviral drug designed to treat adults with mild to moderate symptoms of Covid-19 who are at high risk of severe disease.
Most committee members agreed it was a difficult vote, with unanswered questions about the drug’s safety and potential impact, however unlikely, on driving virus evolution.
The drug needs final authorization from the FDA and Centers for Disease Control and Prevention before it’s available to the public on an emergency basis.
Clinical trial 做的就是高危人群，Pfizer 的药也一样。所以批准也只能批准高危人群。普通人继续等吧
嗯 变种肯定不会绝了
如果普通人还要做个trial那等到猴年马月了
很可能原本新冠就是一个失败的attenuated vaccine
是不是政府买了很多，没法退货，FDA配合通过？
抓住小浣熊问一下：5岁娃还有必要打吗？ 自然感染和疫苗哪个风险更小一点？
当然是疫苗风险小了，５岁小朋友在幼儿园里基本都是在裸奔, 我们这里最近很多小孩确诊阳性了，当然他们症状也是非常的轻甚至几乎没有
如果自然感染都是轻症或者无症状，那岂不是不打疫苗比较好？ 毕竟打了总归有点反应或者副作用，不打也未必会感染。我自己理解啊，我也不懂
也很有道理的样子哦, 不过你这个打了疫苗＂总归＂用得不准确，我身边见到的例子是没有一个小孩子打完疫苗有任何反应
无症状不代表对身体没损害。我就知道有些小孩没症状，但是失去嗅觉，就是伤到神经了
都失去嗅觉这么严重了，还是叫有症状吧
听完以后， 我 LG 就约了打 booster。 今天打完，看他反应如何， 反应不强的话， 我隔几天也去打。
我只想知道daycare的孙子孙女怎么样了？毕竟大人和孩子的免疫力是不同的，而且大多数成人已经毫无顾虑的打了疫苗了，现在就是担心疫苗对孩子的长期影响。我们不是先知，大家都在盲人摸象，就是不希望一个错误的决定导致今后后悔。
daycare 的孙子孙女5岁不到，当然是没打疫苗， 孩子啥事都没有。 正因为如此，所以全家人都不知道孩子已经携带了病毒， 直到老人出现症状才全家去测。老两口平时帮接送。教练才六十多，这么突然死掉， 真是让人心里难以接受。
孙子孙女不会怎么样
目前看，打疫苗不能降低感染后的死亡。。。。。
“症状轻微” so no big deal for vaccinated people
无症状有可能长期损害，不要抱侥幸心理
这是胡说八道了
未打疫苗的死亡率是8倍于已达疫苗的
的确可惜。 年纪越大，越是要去打疫苗啊。 记得那时候疫苗刚出来的时候，为给父母约疫苗的appointment，花了不少时间心思，最后打上了才算放心。
没有实事求是的态度，只能被洗脑吧。。
有效率不是才30几percent吗，跟感冒喝鸡汤橘子汁差不多吧
之前就抨击过FAA， CDC，FDA，已经失去了公信力，成为政府和大公司的傀儡。
政府买了很多默克的药，FDA怎么能不批准？
你有没有常识？研究疫苗对新型变种需要时间你懂吗？无论疫苗是否有效封锁边境都是防止早期扩散的最有效率的方法
和上dc的没疫苗的小娃亲密接触的老人还敢不打疫苗。。。唉
这一看就是假的。以色列一共才5个人确诊Omicron，怎么得到有效率90%的结果？最快也是两周后看到体外的数据吧。
想想癌症药物就理解了
你忘了CDC在统计疫苗死亡率重症率上不同的标准（包括病毒浓度， 多少天发病算副作用等等）
Later in the evening, a report by Channel 12 said the Pfizer vaccine is just slightly less effective in preventing infection with Omicron than with Delta – 90% as opposed to 95% – while it is as effective – around 93% – in preventing serious symptoms at least for those vaccinated with a booster.
A spokesperson for the Health Ministry said the ministry was not yet in possession of the data published by Channel 12.
全篇报道：
https://www.jpost.com/health-and-wellness/coronavirus/covid-1st-data-about-vaccine-efficacy-against-omicron-expected-tuesday-687392
辉瑞疫苗不是辉瑞研发的，而是德国的BioNTech。他家只是做三期，生产和销售。所以应该是德国BioNTech的CEO出来说一说。
打了疫苗，突破率也不小的。。。
good news.
第一时间封国是合理的。数据这周才出来，可以调整。 不封国，任这个未知的变异随便进入他们国家，才是不合理的。
恰恰相反，各个国家现在采取的都是很负责任很审慎的态度。
感冒喝鸡汤有效率是0